Tag Archives: Opdivo

Keytruda, Similar Cancer Drugs May Increase Risk of Pulmonary Embolism: Study

October 17, 2024 By: Martha Garcia

Findings come after a panel of scientific advisors already called for more restrictions on Keytruda, Opdivo and similar cancer drugs last month, due to moderate benefits and high risks.
FDA Advisors Vote for Restrictions on Opdivo, Keytruda, Similar Stomach Cancer Drugs

September 30, 2024 By: Irvin Jackson

Panel of independent experts found little to no evidence that these drugs extend the lives of stomach cancer patients.
FDA Advisors Set to Consider Stomach Cancer Restrictions for Yervoy, Opdivo, Keytruda

August 23, 2024 By: Irvin Jackson

Scientists will meet next month, to make recommendations to the FDA about whether the risks with Opdivo, Keytruda and Yervoy outweigh benefits for stomach cancer treatment.
Opdivo Could Extend Life of Mesothelioma Victims: Study

February 03, 2021 By: Martha Garcia
FDA Approves Opdivo, Yervoy Drug Combo To Treat Mesothelioma

October 05, 2020 By: Irvin Jackson
Only One-Fifth Of Cancer Drugs Approved Through Accelerated FDA Program Actually Work: Study

May 31, 2019 By: Martha Garcia
Opdivo Multiple Myeloma Clinical Trials Halted Following Keytruda Deaths

September 08, 2017 By: Russell Maas
Opdivo/Yervoy Drug Combo Toxic For Most Cancer Patients: Study

August 24, 2017 By: Irvin Jackson
Opdivo, Yervoy Treatments May Slow Mesothelioma Progression: Study

June 14, 2017 By: Irvin Jackson
Some Drug Companies, Hospitals Oversell Cancer Treatment Benefits: CNN Report

April 27, 2017 By: Martha Garcia

Lawyers in Hair Relaxer Cancer Lawsuits Fail To Reach Agreement on Bellwether Plan (Posted 5 days ago)

Judge presiding over all federal hair relaxer lawsuits has ordered the parties to submit separate briefing on the bellwether selection process by January 3.

Depo-Provera Lawsuit MDL Application Will Be Considered by JPML at Hearing on Jan. 30, 2025 (Posted 6 days ago)

With a growing number of women pursuing Depo-Provera brain tumor lawsuits throughout the federal court system, the U.S. JPML will decide whether to consolidate and centralize the claims before one judge for coordinated discovery and pretrial proceedings.

AngioDynamics Port Catheter Lawyers Seek Leadership Roles in MDL (Posted 7 days ago)

A proposal has been submitted for a group of 12 lawyers involved in AngioDynamics port catheter lawsuits to serve in various leadership positions in the litigation, which involves dozens of claims that the implants were defectively designed, leading to fractures, migration and infections.

Tag Archives: Opdivo

Keytruda, Similar Cancer Drugs May Increase Risk of Pulmonary Embolism: Study

FDA Advisors Vote for Restrictions on Opdivo, Keytruda, Similar Stomach Cancer Drugs

FDA Advisors Set to Consider Stomach Cancer Restrictions for Yervoy, Opdivo, Keytruda

Opdivo Could Extend Life of Mesothelioma Victims: Study

FDA Approves Opdivo, Yervoy Drug Combo To Treat Mesothelioma

Only One-Fifth Of Cancer Drugs Approved Through Accelerated FDA Program Actually Work: Study

Opdivo Multiple Myeloma Clinical Trials Halted Following Keytruda Deaths

Opdivo/Yervoy Drug Combo Toxic For Most Cancer Patients: Study

Opdivo, Yervoy Treatments May Slow Mesothelioma Progression: Study

Some Drug Companies, Hospitals Oversell Cancer Treatment Benefits: CNN Report

More Top Stories

Review A Case